Physician profile
Yasser Shaweesh
NPI 1194106617
$1,625.90
in general payments reported to CMS, 2019-2025
7 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.93 · 2021: $304 · 2022: $437 · 2023: $390 · 2024: $313 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $898.54 | 2020-2025 | Lifevest |
| Pfizer INC. | $280.64 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $205.11 | 2022-2023 | Xarelto |
| Eisai INC. | $100.00 | 2021 | |
| Shionogi INC | $94.58 | 2022-2024 | Fetroja |
| Novartis Pharmaceuticals Corporation | $23.57 | 2022 | |
| Abbott Laboratories | $23.46 | 2023 | Coroflow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yasser Shaweesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.